Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Ma

Showing results (231-240 of 339) with videos related to

Pageof 34
Sort By:
Diabetes/Metabolism Research and Reviews|September 18, 2025
Development of a Chinese-Specific Clinical Model to Predict Maturity-Onset Diabetes of the YoungSandra T F Tsoi, Cadmon K P Lim, Ronald C W Ma, et al.
Diabetes Care|October 27, 2006
Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetesPeter C Y Tong, Alice P S Kong, Wing-Yee So, et al.
Diabetes Care|August 29, 2006
Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patientsWing Yee So, Alice P S Kong, Ronald C W Ma, et al.
Diabetes Research and Clinical Practice|January 1, 2015
Delivery of integrated diabetes care using logistics and information technology--the Joint Asia Diabetes Evaluation (JADE) programJuliana C N Chan, Risa Ozaki, Andrea Luk, et al.
Clinical Biochemistry|August 4, 2007
Reference values for serum levels of insulin-like growth factor (IGF-1) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescentsAlice P S Kong, Gary W K Wong, Kai-Chow Choi, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
CYP2C19 Loss-of-function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 DiabetesKe Wang, Aimin Yang, Mai Shi, et al.
Diabetes Research and Clinical Practice|October 5, 2010
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes RegistryXilin Yang, Wing Yee So, Ronald C W Ma, et al.
The Lancet Regional Health. Western Pacific|April 16, 2025
Identifying and visualising temporal trajectories of hospitalisations for traditional and non-traditional complications in people with type 2 diabetes: a population-based studyHongjiang Wu, Haobin Zhou, Chuiguo Huang, et al.
Archives of Internal Medicine|March 12, 2008
Development and validation of an all-cause mortality risk score in type 2 diabetes, Xilin Yang, Wing Yee So, et al.
Diabetes Care|October 7, 2008
Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes RegistryAndrea O Y Luk, Wing-Yee So, Ronald C W Ma, et al.
Pageof 34

Showing results (231-240 of 339) with videos related to

Sort By:
Pageof 34
Diabetes/Metabolism Research and Reviews|September 18, 2025
Development of a Chinese-Specific Clinical Model to Predict Maturity-Onset Diabetes of the YoungSandra T F Tsoi, Cadmon K P Lim, Ronald C W Ma, et al.
Diabetes Care|October 27, 2006
Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetesPeter C Y Tong, Alice P S Kong, Wing-Yee So, et al.
Diabetes Care|August 29, 2006
Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patientsWing Yee So, Alice P S Kong, Ronald C W Ma, et al.
Diabetes Research and Clinical Practice|January 1, 2015
Delivery of integrated diabetes care using logistics and information technology--the Joint Asia Diabetes Evaluation (JADE) programJuliana C N Chan, Risa Ozaki, Andrea Luk, et al.
Clinical Biochemistry|August 4, 2007
Reference values for serum levels of insulin-like growth factor (IGF-1) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescentsAlice P S Kong, Gary W K Wong, Kai-Chow Choi, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
CYP2C19 Loss-of-function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 DiabetesKe Wang, Aimin Yang, Mai Shi, et al.
Diabetes Research and Clinical Practice|October 5, 2010
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes RegistryXilin Yang, Wing Yee So, Ronald C W Ma, et al.
The Lancet Regional Health. Western Pacific|April 16, 2025
Identifying and visualising temporal trajectories of hospitalisations for traditional and non-traditional complications in people with type 2 diabetes: a population-based studyHongjiang Wu, Haobin Zhou, Chuiguo Huang, et al.
Archives of Internal Medicine|March 12, 2008
Development and validation of an all-cause mortality risk score in type 2 diabetes, Xilin Yang, Wing Yee So, et al.
Diabetes Care|October 7, 2008
Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes RegistryAndrea O Y Luk, Wing-Yee So, Ronald C W Ma, et al.
Pageof 34